期刊文献+

26例抗着丝点抗体阳性分析 被引量:2

Clinical analysis of anticentromere antibodies positive in 26 cases
下载PDF
导出
摘要 目的:提高临床对抗着丝点抗体的认识。方法:回顾分析了26例抗着丝点抗体阳性患者临床资料。结果:26例抗着丝点抗体阳性患者中系统性硬化症10例(38.4%),系统性红斑狼疮4例(15.4%),干燥综合症和类风湿关节炎分别3例(11.5%),混合结缔组织病、仅有雷诺现象各2例(7.7%),CREST综合征和不明原因肝脏疾病各1例(3.8%)。着丝点抗体可同时出现其它自身抗体。结论:抗着丝点抗体可出现在多种疾病中,着丝点抗体并非CREST综合征的特异性抗体,抗着丝点抗体阳性患者最多见临床症状为雷诺现象(53.8%),其次为皮肤硬化(34.6%)。 Objective:To comprehend the clinical significance of anticentromere antibodies(ACA)positive in patients.Methods:A total of 26 patients with positive ACA were studied retrospectively.Results:There were 10 patients with systemic sclerosis(38.4%),4 patients with systemic lupus erythematosus(15.4%),3 patients with Sjogren's syndrome and rheumatoid arthritis(11.5%)respectively,2 patients with mixed connective tissue disease and Raynaud phenomenon(7.7%)respectively,1 patient with CREST syndrome and 1 patient with liver disease of unknown causes (3.8%).ACA and other autoantibodies were present in serum at the same time.Conclusion:ACA is found in many diseases.ACA is not specific for CREST syndrome.The major clinical characteristics of the patients correlated with ACA are Raynaud phenomenon(53.8%)and scleroderma(34.6%).
出处 《重庆医科大学学报》 CAS CSCD 2005年第3期461-462,484,共3页 Journal of Chongqing Medical University
关键词 抗着丝点抗体 系统性硬化症 雷诺现象 Anticertromere antibodies Systemic sclerosis Raynaud phenomenon
  • 相关文献

参考文献5

  • 1张乃峥主编..临床风湿病学[M].上海:上海科学技术出版社,1999:441.
  • 2Gonzalez - Buitrago JM, Gonzaez C, Hernando M, et al.Antibodies to centromere antigens measured by an automated enzyme immunoassay [ J ]. Clin Chim Acta, 2003,328( 1 - 2 ) : 135 - 138. 被引量:1
  • 3Nakano M, Ohuchi Y, Hasegawa H, et al. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus[ J ]. J Rheurnatol,2000 ,27(6) : 1403 — 1407. 被引量:1
  • 4Katano K, Kawano M, Koni 1, et al. Clinical and laboratory features of anticentromere antibody positive primary Sjogren's syndrome[ J ]. J Rheumatol, 2001 , 28 (10) : 2238 — 2244. 被引量:1
  • 5Russo K, Hoch S, Dirna C, et al. Circulating anticentromere CENP - A and CENP - B antibodies in patients with diffusw and limited systemic sclerosis, systemic lupus erythernatosus, and rheumatoid arthritis [ J ]. J Rheurnatol, 2000, 27(1) : 142 — 148. 被引量:1

同被引文献17

  • 1高明,谭爱国,刘爱华,谢志贤.52例抗着丝点抗体阳性患者临床分析[J].中国实验诊断学,2005,9(1):61-63. 被引量:5
  • 2于慧敏,张凤山.系统性硬化症发病机制研究进展[J].中华风湿病学杂志,2005,9(6):362-365. 被引量:13
  • 3严月华,王兴刚,廖康煌,郑雪莲.系统性硬皮病46例临床分析[J].中国麻风皮肤病杂志,2006,22(9):741-742. 被引量:2
  • 4Villalta D, Bizzaro N, Platzgummer S, et al. Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti - topoisomerase I (Scl-70) antibodies[J]. Clin Rheumatol, 2005,24(5) :453-459. 被引量:1
  • 5Hayakawa I, Hasegawa M, Takehara K, et al. Anti-DNA topoisomerase IIα autoantibodies in Japanese patients with systemic sclerosis [J].Arch Dermatol Res, 2005,297 (4): 180-183. 被引量:1
  • 6Imafuku Y. Anticentromere antibody[J].Nihon Rinsho,2010,(Suppl 6):S506-S509. 被引量:1
  • 7Imafuku Y. Immunologic tests:Anticentromere antibody[J].Nihon Rinsho,2005,(Suppl 7):S460-S463. 被引量:1
  • 8Vlachoyiannopoulos PG,Moutsopoulos HM. Anticentromere (ACA)-positive Sj(o)gren′s syndrome:a disease entity[J].{H}Clinical and Experimental Rheumatology,2013,(02):163-164. 被引量:1
  • 9Admou B,Essaadouni L,Amal S. Autoantibodies in systemic sclerosis:clinical interest and diagnosis approach[J].{H}Annales de Biologie Clinique(Paris),2009,(03):273-281. 被引量:1
  • 10吴建伟,黄成龙,华春珍,李珊.系统性硬化症731例分析[J].浙江预防医学,2008,20(7):80-81. 被引量:4

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部